ARTICLE | Clinical News
Glythera preclinical data
November 3, 2014 8:00 AM UTC
In a mouse xenograft model of cancer, an antibody-drug conjugate (ADC) containing Glythera's PermaLink linker led to increased anticancer activity vs. an ADC containing a maleimide-based linker. Data ...